25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biostem Technologies Inc
Buy, Hold or Sell?

Let's analyze Biostem Technologies Inc together

I guess you are interested in Biostem Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biostem Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biostem Technologies Inc

I send you an email if I find something interesting about Biostem Technologies Inc.

1. Quick Overview

1.1. Quick analysis of Biostem Technologies Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biostem Technologies Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.24
Expected worth in 1 year
$0.21
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
$0.45
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
$22.80
Expected price per share
$14.32 - $
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biostem Technologies Inc (5 min.)




Live pricePrice per Share (EOD)
$22.80
Intrinsic Value Per Share
$-1.62 - $-0.53
Total Value Per Share
$-1.86 - $-0.77

2.2. Growth of Biostem Technologies Inc (5 min.)




Is Biostem Technologies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.9m-$5.7m$1.8m46.7%

How much money is Biostem Technologies Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$1.4m-$5.6m-79.6%
Net Profit Margin-102.9%-33.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Biostem Technologies Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biostem Technologies Inc?

Welcome investor! Biostem Technologies Inc's management wants to use your money to grow the business. In return you get a share of Biostem Technologies Inc.

First you should know what it really means to hold a share of Biostem Technologies Inc. And how you can make/lose money.

Speculation

The Price per Share of Biostem Technologies Inc is $22.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biostem Technologies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biostem Technologies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.24. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biostem Technologies Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-1.9%-0.43-1.9%-0.09-0.4%-0.31-1.3%-0.25-1.1%
Usd Book Value Change Per Share0.110.5%0.110.5%-0.010.0%-0.07-0.3%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.110.5%0.110.5%-0.010.0%-0.07-0.3%0.000.0%
Usd Price Per Share2.99-2.99-1.04-2.24-5.28-
Price to Earnings Ratio-6.88--6.88--11.72--8.36--24.63-
Price-to-Total Gains Ratio26.41-26.41--104.98--25.42-12.65-
Price to Book Ratio-12.33--12.33--2.92--12.19-61.57-
Price-to-Total Gains Ratio26.41-26.41--104.98--25.42-12.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share22.8
Number of shares43
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.11-0.07
Usd Total Gains Per Share0.11-0.07
Gains per Quarter (43 shares)4.87-2.86
Gains per Year (43 shares)19.47-11.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101990-11-21
2039280-23-32
3058470-34-43
4078660-46-54
5097850-57-65
601171040-69-76
701361230-80-87
801561420-91-98
901751610-103-109
1001951800-114-120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.05.00.044.4%6.07.00.046.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.013.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.05.00.044.4%6.07.00.046.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biostem Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1130.1130%-0.010+109%-0.066+159%0.004+2974%
Book Value Per Share---0.243-0.2430%-0.356+47%-0.258+6%-0.116-52%
Current Ratio--0.2350.2350%0.143+64%0.212+11%0.374-37%
Debt To Asset Ratio--2.1392.1390%3.169-32%2.411-11%1.554+38%
Debt To Equity Ratio----0%-0%-0%0.741-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.434-0.4340%-0.089-80%-0.305-30%-0.247-43%
Free Cash Flow Per Share---0.129-0.1290%-0.009-93%-0.094-27%-0.104-19%
Free Cash Flow To Equity Per Share---0.094-0.0940%0.013-847%-0.017-82%-0.018-81%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.532--------
Intrinsic Value_10Y_min---1.619--------
Intrinsic Value_1Y_max---0.057--------
Intrinsic Value_1Y_min---0.120--------
Intrinsic Value_3Y_max---0.169--------
Intrinsic Value_3Y_min---0.399--------
Intrinsic Value_5Y_max---0.277--------
Intrinsic Value_5Y_min---0.719--------
Market Cap371350440.000+87%48699027.00048699027.0000%16938792.000+188%36418402.800+34%85930166.070-43%
Net Profit Margin---1.029-1.0290%-0.333-68%-2.437+137%-5.461+431%
Operating Margin---0.681-0.6810%-0.370-46%-0.210-69%-4.088+500%
Operating Ratio--1.8091.8090%1.710+6%3.728-51%6.625-73%
Pb Ratio-94.014-663%-12.329-12.3290%-2.923-76%-12.191-1%61.569-120%
Pe Ratio-52.489-663%-6.883-6.8830%-11.719+70%-8.355+21%-24.631+258%
Price Per Share22.800+87%2.9902.9900%1.040+188%2.236+34%5.276-43%
Price To Free Cash Flow Ratio-176.294-663%-23.119-23.1190%-111.229+381%-46.008+99%-59.380+157%
Price To Total Gains Ratio201.366+87%26.40726.4070%-104.976+498%-25.419+196%12.648+109%
Quick Ratio--0.0060.0060%0.046-87%0.020-71%0.036-84%
Return On Assets---2.041-2.0410%-0.541-73%-1.450-29%-1.281-37%
Return On Equity----0%-0%-0%-1.4840%
Total Gains Per Share--0.1130.1130%-0.010+109%-0.066+159%0.004+2974%
Usd Book Value---3949953.000-3949953.0000%-5794107.000+47%-4197114.600+6%-1891413.333-52%
Usd Book Value Change Per Share--0.1130.1130%-0.010+109%-0.066+159%0.004+2974%
Usd Book Value Per Share---0.243-0.2430%-0.356+47%-0.258+6%-0.116-52%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.434-0.4340%-0.089-80%-0.305-30%-0.247-43%
Usd Free Cash Flow---2106427.000-2106427.0000%-152287.000-93%-1535780.800-27%-1695777.556-19%
Usd Free Cash Flow Per Share---0.129-0.1290%-0.009-93%-0.094-27%-0.104-19%
Usd Free Cash Flow To Equity Per Share---0.094-0.0940%0.013-847%-0.017-82%-0.018-81%
Usd Market Cap371350440.000+87%48699027.00048699027.0000%16938792.000+188%36418402.800+34%85930166.070-43%
Usd Price Per Share22.800+87%2.9902.9900%1.040+188%2.236+34%5.276-43%
Usd Profit---7074861.000-7074861.0000%-1445383.000-80%-4967894.400-30%-4022826.333-43%
Usd Revenue--6875202.0006875202.0000%4340839.000+58%3477038.000+98%2052497.444+235%
Usd Total Gains Per Share--0.1130.1130%-0.010+109%-0.066+159%0.004+2974%
 EOD+7 -1MRQTTM+0 -0YOY+15 -165Y+17 -1410Y+12 -20

3.3 Fundamental Score

Let's check the fundamental score of Biostem Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-52.489
Price to Book Ratio (EOD)Between0-1-94.014
Net Profit Margin (MRQ)Greater than0-1.029
Operating Margin (MRQ)Greater than0-0.681
Quick Ratio (MRQ)Greater than10.006
Current Ratio (MRQ)Greater than10.235
Debt to Asset Ratio (MRQ)Less than12.139
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.041
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biostem Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose20.700
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Biostem Technologies Inc

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Fundamental data was last updated by Penke on 2024-10-24 02:04:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biostem Technologies Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -102.9% means that $-1.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biostem Technologies Inc:

  • The MRQ is -102.9%. The company is making a huge loss. -2
  • The TTM is -102.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-102.9%TTM-102.9%0.0%
TTM-102.9%YOY-33.3%-69.6%
TTM-102.9%5Y-243.7%+140.8%
5Y-243.7%10Y-546.1%+302.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-102.9%-135.3%+32.4%
TTM-102.9%-204.4%+101.5%
YOY-33.3%-207.5%+174.2%
5Y-243.7%-353.2%+109.5%
10Y-546.1%-464.5%-81.6%
4.3.1.2. Return on Assets

Shows how efficient Biostem Technologies Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • -204.1% Return on Assets means that Biostem Technologies Inc generated $-2.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biostem Technologies Inc:

  • The MRQ is -204.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -204.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-204.1%TTM-204.1%0.0%
TTM-204.1%YOY-54.1%-150.0%
TTM-204.1%5Y-145.0%-59.1%
5Y-145.0%10Y-128.1%-17.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-204.1%-10.7%-193.4%
TTM-204.1%-11.8%-192.3%
YOY-54.1%-11.0%-43.1%
5Y-145.0%-12.6%-132.4%
10Y-128.1%-14.3%-113.8%
4.3.1.3. Return on Equity

Shows how efficient Biostem Technologies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biostem Technologies Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biostem Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-148.4%+148.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--15.9%+15.9%
YOY--13.5%+13.5%
5Y--18.5%+18.5%
10Y-148.4%-19.0%-129.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biostem Technologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biostem Technologies Inc is operating .

  • Measures how much profit Biostem Technologies Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • An Operating Margin of -68.1% means the company generated $-0.68  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biostem Technologies Inc:

  • The MRQ is -68.1%. The company is operating very inefficient. -2
  • The TTM is -68.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-68.1%TTM-68.1%0.0%
TTM-68.1%YOY-37.0%-31.1%
TTM-68.1%5Y-21.0%-47.1%
5Y-21.0%10Y-408.8%+387.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.1%-277.1%+209.0%
TTM-68.1%-312.4%+244.3%
YOY-37.0%-223.5%+186.5%
5Y-21.0%-384.9%+363.9%
10Y-408.8%-494.6%+85.8%
4.3.2.2. Operating Ratio

Measures how efficient Biostem Technologies Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are $1.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biostem Technologies Inc:

  • The MRQ is 1.809. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.809. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.809TTM1.8090.000
TTM1.809YOY1.710+0.100
TTM1.8095Y3.728-1.919
5Y3.72810Y6.625-2.896
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8092.842-1.033
TTM1.8093.179-1.370
YOY1.7103.301-1.591
5Y3.7284.794-1.066
10Y6.6256.520+0.105
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biostem Technologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biostem Technologies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.23 means the company has $0.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biostem Technologies Inc:

  • The MRQ is 0.235. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.235. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.2350.000
TTM0.235YOY0.143+0.091
TTM0.2355Y0.212+0.023
5Y0.21210Y0.374-0.162
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2353.783-3.548
TTM0.2353.923-3.688
YOY0.1434.715-4.572
5Y0.2125.960-5.748
10Y0.3746.285-5.911
4.4.3.2. Quick Ratio

Measures if Biostem Technologies Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biostem Technologies Inc:

  • The MRQ is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.006TTM0.0060.000
TTM0.006YOY0.046-0.040
TTM0.0065Y0.020-0.015
5Y0.02010Y0.036-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0063.349-3.343
TTM0.0063.522-3.516
YOY0.0464.691-4.645
5Y0.0205.927-5.907
10Y0.0366.469-6.433
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biostem Technologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biostem Technologies Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biostem Technologies Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.14 means that Biostem Technologies Inc assets are financed with 213.9% credit (debt) and the remaining percentage (100% - 213.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biostem Technologies Inc:

  • The MRQ is 2.139. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.139. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.139TTM2.1390.000
TTM2.139YOY3.169-1.029
TTM2.1395Y2.411-0.272
5Y2.41110Y1.554+0.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1390.338+1.801
TTM2.1390.347+1.792
YOY3.1690.309+2.860
5Y2.4110.365+2.046
10Y1.5540.380+1.174
4.5.4.2. Debt to Equity Ratio

Measures if Biostem Technologies Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biostem Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.741-0.741
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.389-0.389
TTM-0.437-0.437
YOY-0.375-0.375
5Y-0.450-0.450
10Y0.7410.488+0.253
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biostem Technologies Inc generates.

  • Above 15 is considered overpriced but always compare Biostem Technologies Inc to the Biotechnology industry mean.
  • A PE ratio of -6.88 means the investor is paying $-6.88 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biostem Technologies Inc:

  • The EOD is -52.489. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.883. Based on the earnings, the company is expensive. -2
  • The TTM is -6.883. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-52.489MRQ-6.883-45.605
MRQ-6.883TTM-6.8830.000
TTM-6.883YOY-11.719+4.836
TTM-6.8835Y-8.355+1.472
5Y-8.35510Y-24.631+16.276
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-52.489-2.431-50.058
MRQ-6.883-2.454-4.429
TTM-6.883-2.994-3.889
YOY-11.719-3.435-8.284
5Y-8.355-6.005-2.350
10Y-24.631-6.275-18.356
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biostem Technologies Inc:

  • The EOD is -176.294. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.119. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.119. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-176.294MRQ-23.119-153.175
MRQ-23.119TTM-23.1190.000
TTM-23.119YOY-111.229+88.110
TTM-23.1195Y-46.008+22.888
5Y-46.00810Y-59.380+13.372
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-176.294-3.231-173.063
MRQ-23.119-3.234-19.885
TTM-23.119-3.528-19.591
YOY-111.229-4.567-106.662
5Y-46.008-8.099-37.909
10Y-59.380-8.945-50.435
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biostem Technologies Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -12.33 means the investor is paying $-12.33 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biostem Technologies Inc:

  • The EOD is -94.014. Based on the equity, the company is expensive. -2
  • The MRQ is -12.329. Based on the equity, the company is expensive. -2
  • The TTM is -12.329. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-94.014MRQ-12.329-81.685
MRQ-12.329TTM-12.3290.000
TTM-12.329YOY-2.923-9.406
TTM-12.3295Y-12.191-0.138
5Y-12.19110Y61.569-73.760
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-94.0141.938-95.952
MRQ-12.3291.983-14.312
TTM-12.3292.193-14.522
YOY-2.9232.392-5.315
5Y-12.1913.608-15.799
10Y61.5694.220+57.349
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,466
Total Liabilities7,416
Total Stockholder Equity-4,076
 As reported
Total Liabilities 7,416
Total Stockholder Equity+ -4,076
Total Assets = 3,466

Assets

Total Assets3,466
Total Current Assets1,487
Long-term Assets1,980
Total Current Assets
Cash And Cash Equivalents 772
Net Receivables 37
Inventory 395
Other Current Assets 282
Total Current Assets  (as reported)1,487
Total Current Assets  (calculated)1,487
+/-0
Long-term Assets
Property Plant Equipment 1,373
Goodwill 245
Intangible Assets 363
Long-term Assets  (as reported)1,980
Long-term Assets  (calculated)1,980
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,328
Long-term Liabilities1,088
Total Stockholder Equity-4,076
Total Current Liabilities
Short Long Term Debt 4,042
Accounts payable 570
Other Current Liabilities 159
Total Current Liabilities  (as reported)6,328
Total Current Liabilities  (calculated)4,771
+/- 1,557
Long-term Liabilities
Long term Debt 1,026
Capital Lease Obligations Min Short Term Debt21
Other Liabilities 51
Long-term Liabilities Other 51
Long-term Liabilities  (as reported)1,088
Long-term Liabilities  (calculated)1,148
+/- 60
Total Stockholder Equity
Common Stock12
Total Stockholder Equity (as reported)-4,076
Total Stockholder Equity (calculated)12
+/- 4,089
Other
Capital Stock12
Common Stock Shares Outstanding 12,161
Net Debt 4,296
Net Invested Capital 992
Net Tangible Assets -4,684
Net Working Capital -4,842
Property Plant and Equipment Gross 2,383



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312011-12-312010-12-312009-12-311999-12-31
> Total Assets 
6,070
2,046
2,696
3,475
440
2,936
2,738
3,033
4,300
3,154
2,668
2,672
3,466
3,4662,6722,6683,1544,3003,0332,7382,9364403,4752,6962,0466,070
   > Total Current Assets 
2,516
169
80
82
51
785
290
231
1,958
1,067
851
939
1,487
1,4879398511,0671,9582312907855182801692,516
       Cash And Cash Equivalents 
35
169
27
26
51
412
166
48
1,176
141
101
340
772
7723401011411,1764816641251262716935
       Net Receivables 
202
0
53
56
0
152
17
19
185
79
12
300
37
3730012791851917152056530202
       Inventory 
448
0
0
0
0
220
94
147
415
565
571
260
395
395260571565415147942200000448
   > Long-term Assets 
0
0
0
0
0
0
0
2,781
2,342
2,087
1,819
1,733
1,980
1,9801,7331,8192,0872,3422,7810000000
       Property Plant Equipment 
444
1,816
2,211
1,936
91
1,342
1,681
1,678
0
1,581
1,354
1,278
1,373
1,3731,2781,3541,58101,6781,6811,342911,9362,2111,816444
       Goodwill 
3,045
0
0
0
298
630
192
562
465
465
465
245
245
2452454654654655621926302980003,045
       Long Term Investments 
55
0
0
0
0
0
0
0
0
0
0
0
0
00000000000055
       Intangible Assets 
0
61
87
78
0
154
553
427
0
0
0
210
363
36321000042755315407887610
       Long-term Assets Other 
0
0
0
0
0
0
0
0
41
41
0
0
0
000414100000000
> Total Liabilities 
7,965
0
0
0
66
1,292
2,257
1,570
5,972
7,091
8,301
8,466
7,416
7,4168,4668,3017,0915,9721,5702,2571,292660007,965
   > Total Current Liabilities 
5,572
0
0
0
54
792
1,757
1,098
5,223
5,891
6,797
6,541
6,328
6,3286,5416,7975,8915,2231,0981,757792540005,572
       Short-term Debt 
3,640
0
0
0
0
0
0
0
0
0
0
0
0
0000000000003,640
       Short Long Term Debt 
3,640
0
0
0
0
0
0
955
4,393
3,786
3,994
3,000
4,042
4,0423,0003,9943,7864,3939550000003,640
       Accounts payable 
4,082
0
0
0
24
781
1,307
562
346
688
608
647
570
5706476086883465621,307781240004,082
       Other Current Liabilities 
141
0
0
0
20
11
17
36
0
154
193
337
159
159337193154036171120000141
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
750
1,200
1,504
1,925
1,088
1,0881,9251,5041,20075000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
120
51
5112000000000000
       Deferred Long Term Liability 
0
0
0
0
0
14
0
0
0
0
0
0
0
00000001400000
> Total Stockholder Equity
-1,894
2,045
2,696
3,474
373
1,644
485
1,489
-1,611
-4,086
-5,802
-5,959
-4,076
-4,076-5,959-5,802-4,086-1,6111,4894851,6443733,4742,6962,045-1,894
   Common Stock
15
106
228
290
492
1,252
1,454
2,908
0
0
0
10
12
12100002,9081,4541,25249229022810615
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
12
0
0
0
0
0
-1,225
-857
0
0
0
0
0
00000-857-1,2250000012



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,037
Cost of Revenue-740
Gross Profit5,2975,297
 
Operating Income (+$)
Gross Profit5,297
Operating Expense-14,634
Operating Income-8,597-9,337
 
Operating Expense (+$)
Research Development-
Selling General Administrative13,662
Selling And Marketing Expenses-
Operating Expense14,63413,662
 
Net Interest Income (+$)
Interest Income-
Interest Expense-522
Other Finance Cost-0
Net Interest Income-522
 
Pretax Income (+$)
Operating Income-8,597
Net Interest Income-522
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-9,394-8,323
EBIT - interestExpense = -522
-9,345
-8,823
Interest Expense522
Earnings Before Interest and Taxes (EBIT)--8,872
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-9,394
Tax Provision--
Net Income From Continuing Ops-9,394-9,394
Net Income-9,345
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-274522
 

Technical Analysis of Biostem Technologies Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biostem Technologies Inc. The general trend of Biostem Technologies Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biostem Technologies Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biostem Technologies Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 15.50 > 15.50 > 14.32.

Tweet this
Biostem Technologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biostem Technologies Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biostem Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiostem Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biostem Technologies Inc. The current adx is .

Biostem Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biostem Technologies Inc.

Biostem Technologies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Relative Strength Index (RSI) ChartBiostem Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biostem Technologies Inc.

Biostem Technologies Inc Daily Stochastic Oscillator ChartBiostem Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Commodity Channel Index (CCI) ChartBiostem Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartBiostem Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biostem Technologies Inc.

Biostem Technologies Inc Daily Williams %R ChartBiostem Technologies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biostem Technologies Inc.

Biostem Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Average True Range (ATR) ChartBiostem Technologies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biostem Technologies Inc.

Biostem Technologies Inc Daily On-Balance Volume (OBV) ChartBiostem Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biostem Technologies Inc.

Biostem Technologies Inc Daily Money Flow Index (MFI) ChartBiostem Technologies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biostem Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biostem Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biostem Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose20.700
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biostem Technologies Inc with someone you think should read this too:
  • Are you bullish or bearish on Biostem Technologies Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biostem Technologies Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biostem Technologies Inc

I send you an email if I find something interesting about Biostem Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biostem Technologies Inc.

Receive notifications about Biostem Technologies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.